Showing results (1651-1660 of 5,935) with videos related to
Sort By:
Pageof 594
The Prostate|March 6, 2020
Prognostic value of an inflammatory index for patients with metastatic castration-resistant prostate cancerYasutaka Yamada, Shinichi Sakamoto, Junryo Rii, et al.The Prostate|March 6, 2020
Docetaxel-resistant prostate cancer cells become sensitive to gemcitabine due to the upregulation of ABCB1Ho Kyung Seo, Sang-Jin Lee, Whi-An Kwon, et al.The Prostate|January 22, 2019
Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancerDaniel P Petrylak, Philip Kantoff, Nicholas J Vogelzang, et al.The Prostate|January 24, 2019
A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivationYoung Hyo Choi, Deok Hyun Han, Seon-Woo Kim, et al.The Prostate|December 3, 2019
Prostate cancer adverse pathology reclassification in patients undergoing active surveillance in a long-term follow-up seriesGuillermo Fernández-Conejo, Virginia Hernández, Ana Guijarro, et al.The Prostate|December 4, 2019
The clinical predictive factors and postoperative histopathological parameters associated with upgrading after radical prostatectomy: A contemporary analysis with grade groupsSelcuk Erdem, Samed Verep, Sidar Bagbudar, et al.The Prostate|January 1, 1988
Immunocytochemical demonstration of insulin or insulin-like immunoreactivity in the rat prostate glandM S Stahler, B Pansky, G C BuddThe Prostate|January 1, 1988
Significance of duct-acinar dysplasia in prostatic carcinogenesisJ E McNealThe Prostate|December 1, 2020
Validation of a prostate cancer polygenic risk scoreMary H Black, Shuwei Li, Holly LaDuca, et al.The Prostate|December 1, 2020
Impact of radiation dose on recurrence in high-risk prostate cancer patientsMatthew Deek, Wolfgang Lilleby, Victoria Vaage, et al.Pageof 594